16. April 2019 Daniel Kruse

The German Federal Office of Consumers Protection and Food Safety (BVL) changed the Cannabidiol definition on its website
On the 20th of March BVL changed the definition of Cannabidiol (CBD). According to the new definition BVL believes that CBD containing products  either require an application for licensing of a medicine or an application for licensing of a novel food before marketing.
EIHA believes that this public disclosure and recommendation made by BVL is simply wrong in the general way of its statement. In particular, it is factually and legally inaccurate.
EIHA stated, one again, that CBD is:

  • A Natural substance in the Industrial plant Cannabis sativa L. from EU-certified cultivation.
  • The parts of the industrial hemp plants have then to be considered safe as the entire plant (and not medicine).
  • Hemp extracts are not novel
  • CBD-containing plant products can therefore generally be marketable as a food or foor supplement.

Following these principles, EIHA, via our lawyer, Dr Piper, reacted to this change and asked BVL to reformulate this definition (or to withdraw it) by the 26 of April 2019 the latest.
So far EIHA received a letter of confirmation that BVL well received our observations and now we are waiting for their reactions.